SCHEMBL13978040

SCHEMBL13978040

c1cnc(Sc2c[nH]c3cccnc23)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMD14 O00487 1/20 0.43
▸ GRM4 Q14833 1/20 0.39
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36
▸ TUBA1A Q71U36 1/20 0.36
▸ TUBA1C Q9BQE3 1/20 0.36
▸ TUBB6 Q9BUF5 1/20 0.36
▸ TUBB2B Q9BVA1 1/20 0.36
▸ TUBB1 Q9H4B7 1/20 0.36
▸ KCNMA1 Q12791 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22766344 0.80 PSMD14 (0.44) PSMD14GRM4TUBB4ATUBBTUBA3C
SCHEMBL2066259 0.73 PSMD14 (0.48) PSMD14GRM4KCNMA1SLC6A2ADRA1A
SCHEMBL31307015 0.69 PSMD14 (0.48) PSMD14GRM4KCNMA1PARP1MAPT
SCHEMBL13978041 0.69 PSMD14 (0.48) PSMD14GRM4KCNMA1PARP1MAPT
SCHEMBL29364091 0.69 AXL (0.50) PSMD14GRM4KCNMA1PARP1MAPT
SCHEMBL3175822 0.69 PSMD14 (0.48) PSMD14GRM4KCNMA1PARP1MAPT
SCHEMBL569155 0.69 AXL (0.50) PSMD14GRM4KCNMA1PARP1MAPT
SCHEMBL22510135 0.69 PSMD14 (0.48) PSMD14GRM4PARP1MAPTMMP2
SCHEMBL19100792 0.69 GRM4 (0.54) PSMD14GRM4HTR1ASLC6A2PARP1
SCHEMBL2053968 0.69 PSMD14 (0.48) PSMD14GRM4KCNMA1SLC6A2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION USP24, USP36, USP39 PSMD14 7/4885GRM4 3386/4885TUBB4A 2990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback